[en] Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIP(mut)). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (P<0.0001 versus AIP). Cytoplasmic AIP and AHR were detected by IHC in 84.0 and 38.6% of PA respectively, and significantly correlated with each other (P=0.006). Nuclear AHR was detected in a minority of PA (19.7%). The highest AIP expression was observed in somatotrophinomas and non-secreting (NS) PA, and multivariate analysis in somatotrophinomas showed a significantly lower AIP immunostaining in invasive versus non-invasive cases (P=0.019). AIP expression was commonly low in other secreting PA. AIP immunostaining was abolished in a minority of AIP(mut) PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Jaffrain-Rea, Marie-Lise
Angelini, M.
Gargano, D.
Tichomirowa, M. A.
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T et al. 2007 Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 92 1952-1955. (Pubitemid 46997216)
Barouki R, Coumoul X & Fernandez-Salguero P 2007 The aryl hydrocarbon receptor, more than a xenobioticinteracting protein. FEBS Letters 581 3608-3615. (Pubitemid 47080995)
Beckers A & Daly AF 2007 The clinical, pathological, and genetic features of familial isolated pituitary adenomas. European Journal of Endocrinology 157 371-382. (Pubitemid 350018439)
Bell DR & Poland A 2000 Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. Journal of Biological Chemistry 275 36407-36414.
Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS & Houslay MD 2003 Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. Journal of Biological Chemistry 278 33351-33363. (Pubitemid 37055787)
Buchbinder S, Bierhaus A, Zorn M, Nawroth PP, Humpert P & Schilling T 2008 Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas. Experimental and Clinical Endocrinology & Diabetes 116 625-628.
Cazabat L, Libè R, Perlemoine K, René-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P et al. 2007 Germline inactivating mutations of the aryl hydrocarbon receptorinteracting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. European Journal of Endocrinology 157 1-8. (Pubitemid 47162559)
Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T et al. 2006 Clinical characterization of familial isolated pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 91 3316-3323. (Pubitemid 44402097)
Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez- Roqueplo AP, Tamburrano G et al. 2007 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism 92 1891-1896. (Pubitemid 46997206)
Elango A, Shepherd B & Chen TT 2006 Effects of endocrine disruptors on the expression of growth hormone and prolactinmRNAin the rainbowtrout pituitary. General and Comparative Endocrinology 145 116-127. (Pubitemid 43005045)
Ferretti E, Jaffrain-Rea ML, Asteria C, Di Stefano D, Esposito V, Ferrante L, Daniele P, Tiberti C, Gallucci M, Bosman C et al. 2001 Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features. European Journal of Endocrinology 144 227-235. (Pubitemid 32266291)
Fratticci A, Grieco FA, Spilioti C, Giangaspero F, Ventura L, Esposito V, Piccirilli M, Santoro A, Gulino A, Cantore G et al. 2007 Differential expression of neurogenins and NeuroD1 in human pituitary tumours. Journal of Endocrinology 194 475-484. (Pubitemid 47471216)
Fukunaga BN & Hankinson O 1996 Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding. Journal of Biological Chemistry 271 3743-3749. (Pubitemid 26065693)
Fukunaga BN, Probst MR, Reisz-Porszasz S & Hankinson O 1995 Identification of functional domains of the aryl hydrocarbon receptor. Journal of Biological Chemistry 270 29270-29278.
Gasiewicz TA, Henry EC & Collins LL 2008 Expression and activity of aryl hydrocarbon receptors in development and cancer. Critical Reviews in Eukaryotic Gene Expression 18 279-321.
Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Mäkinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T et al. 2007 Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. PNAS 104 4101-4105. (Pubitemid 47181585)
Georgitsi M, De Menis E, Cannavò S, Mäkinen MJ, Tuppurainen K, Pauletto P, Curtò L, Weil RJ, Paschke R, Zielinski G et al. 2008a Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clinical Endocrinology 69 621-627.
Georgitsi M, Heliövaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, Salmela P, Sane T, De Menis E, Cannavò S et al. 2008b Large genomic deletions of aryl hydrocarbon receptor interacting protein (AIP) gene in pituitary adenoma predisposition. Journal of Clinical Endocrinology and Metabolism 93 4146-4151.
Harper PA, Riddick DS & Okey AB 2006 Regulating the key regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochemical Pharmacology 72 267-279.
Huang P, Ceccatelli S, Håkansson H, Grandison L & Rannug A 2002 Constitutive and TCDD-induced expression of Ah receptor-responsive genes in the pituitary. Neurotoxicology 23 783-793.
Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T & Yoshimoto K 2007 The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clinical Endocrinology 66 499-502. (Pubitemid 46434927)
Jackson SM, Barnhart KM, Mellon PL, Gutierrez-Hartmann A & Hoffler JP 1993 Helix-loop-helix proteins are present and differentially expressed in different cell lines from the anterior pituitary. Molecular and Cellular Endocrinology 96 167-176. (Pubitemid 23292676)
Jaffrain-Rea ML, Di Stefano D, Minniti G, Esposito V, Bultrini A, Ferretti E, Santoro A, Faticanti Scucchi L, Gulino A & Cantore G 2002 A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. Endocrine-Related Cancer 9 103-113. (Pubitemid 34832163)
Kang BH & Altieri DC 2006 Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. Journal of Biological Chemistry 281 24721-24727.
Kazlauskas A, Poellinger L & Pongratz I 2002 Two distinct regions of the immunophilin-like protein XAP2 regulate dioxin receptor function and interaction with hsp90. Journal of Biological Chemistry 277 11795-11801. (Pubitemid 34959963)
Kleinjan DA & van Heiningen V 2005 Long-range control of gene expression: emerging mechanisms and disruption in disease. American Journal of Human Genetics 76 8-32. (Pubitemid 40023762)
Korkalainen M, Lindén J, Tuomisto J & Pohjanvirta R 2005 Effect of TCDD on mRNA expression of genes encoding bHLH/PAS proteins in rat hypothalamus. Toxicology 208 1-11. (Pubitemid 40143323)
LaPres JJ, Glover E, Dunham EE, Bunger MK & Bradfield CA 2000 ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. Journal of Biological Chemistry 275 6153-6159. (Pubitemid 30129900)
Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J et al. 2008 The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 93 2390-2401. (Pubitemid 351831563)
Marlowe JL & Puga A 2005 Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. Journal of Cellular Biochemistry 96 1174-1184. (Pubitemid 41681860)
Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, Magalhães AV, Azevedo MF, Giacomini LA, Nascimento PP, Nunes RO et al. 2007 Variable pathological and clinical features of a large Brazilian family harbouring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology 157 383-391. (Pubitemid 350018440)
Nguyen LP & Bradfield CA 2008 The search for endogenous activators of the aryl hydrocarbon receptor. Chemical Research in Toxicology 21 102-116. (Pubitemid 351219712)
Nishimura N, Miyabara Y, Sato M, Yonemoto J & Tohyama C 2002 Immunohistochemical localization of thyroid stimulating hormone induced by a low oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats. Toxicology 171 73-82.
de Oliveira SK, Hoffmeister M, Gambaryan S, Müller-Esterl W, Guimaraes JA & Smolenski AP 2007 Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. Journal of Biological Chemistry 282 13656-13663. (Pubitemid 47100556)
Pesatori A, Baccarelli A, Consonni D, Lania A, Beck-Peccoz P, Bertazzi P & Spada A 2008 Aryl hydrocarbon receptor interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident. European Journal of Endocrinology 159 699-703.
Petrulis JR & Perdew GH 2002 The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chemico-Biological Interactions 141 25-40. (Pubitemid 35223203)
Pitt JA, Buckalew AR, House DE & Abbott BD 2000 Adrenocorticotropin (ACTH) and corticosterone secretion by perifused pituitary and adrenal glands from rodents exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology 151 25-35.
Pocar P, Fischer B, Klonisch T & Hombach-Klonisch S 2005 Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 129 379-389. (Pubitemid 40542164)
Popp JA, Crouch E & McConnell EE 2006 A weight-of-evidence analysis of the cancer dose-response characteristics of 2,3,7,8-tetrachlorodibenzodioxin (TCDD). Toxicological Sciences 89 361-369.
Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, Sonenshein GE & Sherr DH 2006 A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biological Chemistry 387 1175-1187. (Pubitemid 44402063)
Toledo RA, Lourenço DM Jr, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP & Dahia PL 2007 Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. Journal of Clinical Endocrinology and Metabolism 92 1934-1937. (Pubitemid 46997212)
Vargiolu M, Fusco D, Kurelac I, Dirnberger D, Baumeister R, Morra I, Melcarne A, Rimondini R, Romeo G & Bonora E 2009 The tyrosine kinase receptor RET interacts in vivo with AIP to alter survivin availability. Journal of Clinical Endocrinology and Metabolism 94 2571-2578.
Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R et al. 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1228-1230. (Pubitemid 43801151)